HDA UK Media and Political Bulletin – 5 August 2021


  Media Coverage

Parliamentary coverage was also reported by BBC NewsThe Independent and The Telegraph.


 Parliamentary Coverage

JCVI issues updated advice on COVID-19 vaccination of young people aged 16 to 17 – 4 August 2021

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that all 16- and 17-year olds receive their first dose of the Pfizer-BioNTech vaccine.

This updated advice means that young people will be provided around 80% protection against hospitalisation, following receipt of their first dose.

Protection is expected to be even higher as younger people respond better to vaccines and some will have already had the virus, meaning the first dose should act as a ‘booster’ to their immunity.

The JCVI advice recommends prioritising the first dose in younger age groups and delays the recommendation on second does.

The first dose has been prioritised to limit the disruption to education and keep young people well.

The second dose can be given later and will extend protection for a longer period, for example when those young people start work or go to university, or if we begin to get another wave of cases in winter.

Advice on when to offer the second vaccine dose will come later, but it is expected that when the second dose is offered, this will be from 12 weeks after the first dose. A longer gap of 8-to-12-weeks between the first and second doses is beneficial as it offers more protection for a longer period of time.

Professor Wei Shen Lim, COVID-19 Chair for JCVI, said: “While COVID-19 is typically mild or asymptomatic in most young people, it can be very unpleasant for some and for this particular age group, we expect one dose of the vaccine to provide good protection against severe illness and hospitalisation.”


Full Coverage

Parliamentary coverage was also reported by BBC NewsThe Independent and The Telegraph.

HDA UK Media and Political Bulletin –  5 August 2021

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?